tetano
Editor, Senior Moderator
Biol Sex Differ
. 2024 Jun 18;15(1):50.
doi: 10.1186/s13293-024-00625-z. Sex and gender differences in adverse events following influenza and COVID-19 vaccination
Anna Yin[SUP] 1 [/SUP], Nadia Wang[SUP] 2 [/SUP], Patrick J Shea[SUP] 1 [/SUP], Erica N Rosser[SUP] 3 [/SUP], Helen Kuo[SUP] 3 [/SUP], Janna R Shapiro[SUP] 1 [/SUP], Katherine Z J Fenstermacher[SUP] 4 [/SUP], Andrew Pekosz[SUP] 1 4 [/SUP], Richard E Rothman[SUP] 4 [/SUP], Sabra L Klein[SUP] 5 [/SUP], Rosemary Morgan[SUP] 6 [/SUP]
Affiliations
Introduction: Active and passive surveillance studies have found that a greater proportion of females report adverse events (AE) following receipt of either the COVID-19 or seasonal influenza vaccine compared to males. In a predominately young adult female population of healthcare workers, we sought to determine the intersection of biological sex and sociocultural gender differences in prospective active reporting of vaccine outcomes, which remains poorly characterized.
Methods: This cohort study enrolled Johns Hopkins Health System healthcare workers (HCWs) who were recruited from the mandatory annual fall 2019-2022 influenza vaccine and the fall 2022 COVID-19 bivalent vaccine campaigns. Vaccine recipients were enrolled the day of vaccination and AE surveys were administered two days post-vaccination for bivalent COVID-19 and influenza vaccine recipients. Data were collected regarding the presence of a series of solicited local and systemic AEs. Open-ended answers about participants' experiences with AEs also were collected for the COVID-19 vaccine recipients.
Results: Females were more likely to report local AEs after either influenza (OR = 2.28, p = 0.001) or COVID-19 (OR = 2.57, p = 0.008) vaccination compared to males, regardless of age or race. Males and females had comparable probabilities of reporting systemic AEs after either influenza (OR = 1.18, p = 0.552) or COVID-19 (OR = 0.96, p = 0.907) vaccination. Hormonal birth control use did not impact the rates of reported AEs following influenza vaccination among reproductive-aged female HCWs. Women reported more interruptions in their daily routine following COVID-19 vaccination than men and were more likely to seek out self-treatment. More women than men scheduled their COVID-19 vaccination before their days off in anticipation of AEs.
Conclusions: Our findings highlight the need for sex- and gender-inclusive policies to inform more effective mandatory occupational health vaccination strategies. Further research is needed to evaluate the potential disruption of AEs on occupational responsibilities following mandated vaccination for healthcare workers, a predominately female population, and to more fully characterize the post-vaccination behavioral differences between men and women.
Keywords: Birth control; COVID-19 mRNA vaccine; Reactogenicity; Seasonal influenza vaccine; Vaccine hesitancy.
. 2024 Jun 18;15(1):50.
doi: 10.1186/s13293-024-00625-z. Sex and gender differences in adverse events following influenza and COVID-19 vaccination
Anna Yin[SUP] 1 [/SUP], Nadia Wang[SUP] 2 [/SUP], Patrick J Shea[SUP] 1 [/SUP], Erica N Rosser[SUP] 3 [/SUP], Helen Kuo[SUP] 3 [/SUP], Janna R Shapiro[SUP] 1 [/SUP], Katherine Z J Fenstermacher[SUP] 4 [/SUP], Andrew Pekosz[SUP] 1 4 [/SUP], Richard E Rothman[SUP] 4 [/SUP], Sabra L Klein[SUP] 5 [/SUP], Rosemary Morgan[SUP] 6 [/SUP]
Affiliations
- PMID: 38890702
- DOI: 10.1186/s13293-024-00625-z
Introduction: Active and passive surveillance studies have found that a greater proportion of females report adverse events (AE) following receipt of either the COVID-19 or seasonal influenza vaccine compared to males. In a predominately young adult female population of healthcare workers, we sought to determine the intersection of biological sex and sociocultural gender differences in prospective active reporting of vaccine outcomes, which remains poorly characterized.
Methods: This cohort study enrolled Johns Hopkins Health System healthcare workers (HCWs) who were recruited from the mandatory annual fall 2019-2022 influenza vaccine and the fall 2022 COVID-19 bivalent vaccine campaigns. Vaccine recipients were enrolled the day of vaccination and AE surveys were administered two days post-vaccination for bivalent COVID-19 and influenza vaccine recipients. Data were collected regarding the presence of a series of solicited local and systemic AEs. Open-ended answers about participants' experiences with AEs also were collected for the COVID-19 vaccine recipients.
Results: Females were more likely to report local AEs after either influenza (OR = 2.28, p = 0.001) or COVID-19 (OR = 2.57, p = 0.008) vaccination compared to males, regardless of age or race. Males and females had comparable probabilities of reporting systemic AEs after either influenza (OR = 1.18, p = 0.552) or COVID-19 (OR = 0.96, p = 0.907) vaccination. Hormonal birth control use did not impact the rates of reported AEs following influenza vaccination among reproductive-aged female HCWs. Women reported more interruptions in their daily routine following COVID-19 vaccination than men and were more likely to seek out self-treatment. More women than men scheduled their COVID-19 vaccination before their days off in anticipation of AEs.
Conclusions: Our findings highlight the need for sex- and gender-inclusive policies to inform more effective mandatory occupational health vaccination strategies. Further research is needed to evaluate the potential disruption of AEs on occupational responsibilities following mandated vaccination for healthcare workers, a predominately female population, and to more fully characterize the post-vaccination behavioral differences between men and women.
Keywords: Birth control; COVID-19 mRNA vaccine; Reactogenicity; Seasonal influenza vaccine; Vaccine hesitancy.